HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 300 filers reported holding HAEMONETICS CORP in Q4 2019. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $782,401 | -85.5% | 9,455 | -88.3% | 0.02% | -70.6% |
| Q2 2021 | $5,394,000 | +330.5% | 80,935 | +617.1% | 0.05% | +325.0% |
| Q1 2021 | $1,253,000 | +39.8% | 11,287 | +12.9% | 0.01% | -53.8% |
| Q2 2020 | $896,000 | +326.7% | 10,000 | +374.6% | 0.03% | +420.0% |
| Q1 2020 | $210,000 | -83.1% | 2,107 | -80.6% | 0.01% | -80.8% |
| Q4 2019 | $1,246,000 | +41.1% | 10,844 | +54.8% | 0.03% | +18.2% |
| Q3 2019 | $883,000 | -19.8% | 7,003 | -23.5% | 0.02% | 0.0% |
| Q2 2019 | $1,101,000 | -63.1% | 9,150 | -73.1% | 0.02% | -71.4% |
| Q1 2019 | $2,980,000 | +960.5% | 34,062 | +443.3% | 0.08% | +1440.0% |
| Q3 2017 | $281,000 | -77.9% | 6,270 | -80.6% | 0.01% | -75.0% |
| Q2 2017 | $1,274,000 | +278.0% | 32,254 | +246.6% | 0.02% | +300.0% |
| Q3 2016 | $337,000 | – | 9,307 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |